A significant body of literature emerging from the rodent model of MS, myelin oligodendrocyte glycoprotein (MOG)-induced EAE, demonstrates that the DRG and TG undergo major pathologic changes with disease progression (Duffy et al., 2016; Thorburn et al., 2016; Yousuf et al., 2017). The gene discussed is MOG; the disease is myeloid sarcoma.